(607) 227-8695info@prendismo.com

Tom Fuerst Discusses Changes That Occur As Life Science Companies Move Towards Commercialization

Copyright © Cornell University Play All Videos in Case

Total Case Duration :

  • Date Added : 4/19/12
  • Clip Duration : 0 min. 0 sec.

Playlists

Please Login to create playlists

Tom Fuerst

  • VP and CSO, PharmAthene
  • male
  • Caucasian
  • 1958 (Age: 66 years old)
  • Tom Fuerst - Panel - Intersection of Opportunity: Business and the Life Science
  • Video 1 of 9 in this Case
  • View All Available Videos

Biography

Tom Fuerst is the VP and Chief Scientific Officer at PharmAthene. Prior to joining PharmAthene in April 2010, Dr. Fuerst served as Director, Vaccines and Biologics (2004-2007), and Senior Science and Technology Advisor (2007-2010) for the U.S. Department of Health and Human Services (HHS). In these positions, he led the development and acquisition of vaccines and biotherapeutic products for biodefense and other emerging public health threats, including anthrax, smallpox, botulism, and pandemic flu. During his tenure at HHS, Dr. Fuerst helped establish the Biomedical Advanced Research and Development Authority (BARDA) and oversaw the planning, implementation, and monitoring of medical countermeasure development and acquisition, while managing a budget of approximately $3.0 billion. Previously, Dr. Fuerst served as Executive Director of Corporate Development at Sanofi Pasteur, Inc., where he oversaw the scientific and business transactions for vaccines and immunotherapeutic products for infectious diseases and cancer, and played a key role in establishing the company's biodefense initiative post 9/11. He also led a collaborative R&D group to develop a next generation anthrax vaccine in response to the National Institute of Health's Request for Proposal. Prior thereto, he was Vice President, Research and Development at Genelabs Technologies, and a scientific founder and Director of Molecular Genetics at MedImmune. He also served as a senior fellow at the National Institutes of Health, NIAID in Bethesda, MD. Dr. Fuerst holds a B.A. in Biochemistry from the University of California at Berkeley, a Ph.D. in Molecular Genetics from Cornell University, and a MBA in Science, Technology, and Innovation from the George Washington University.

You know often times in, in biotechnology or biopharmaceutical companies, you know, in the beginning when it's very technology laden, you know, where it has very much of an R&D focus, my personal opinion is that's very good to have a scientist or an engineer with business background with experience ...(Full transcript available to logged in subscribers.).

Register & Subscribe Login

Tom Fuerst videos

Video 1 of 9 Tom Fuerst Discusses Professional Background
  • Tom Fuerst - Panel - Intersection of Opportunity: Business and the Life Science
  • 4/19/12
  • Tom Fuerst
  • 0 min. 0 sec.
Video 2 of 9 Tom Fuerst Discusses Challenges of Product Development in Life Science Companies
  • Tom Fuerst - Panel - Intersection of Opportunity: Business and the Life Science
  • 4/19/12
  • Tom Fuerst
  • 0 min. 0 sec.
Video 3 of 9 Tom Fuerst Discusses Relationship and Understanding Between Scientists And Businesspeople During Product Development
  • Tom Fuerst - Panel - Intersection of Opportunity: Business and the Life Science
  • 4/19/12
  • Tom Fuerst
  • 0 min. 0 sec.
Video 4 of 9 Tom Fuerst Discusses Organizational Conflicts Between Science Person and Business Person
  • Tom Fuerst - Panel - Intersection of Opportunity: Business and the Life Science
  • 4/19/12
  • Tom Fuerst
  • 0 min. 0 sec.
Video 5 of 9 Tom Fuerst Discusses Changes That Occur As Life Science Companies Move Towards Commercialization
  • Tom Fuerst - Panel - Intersection of Opportunity: Business and the Life Science
  • 4/19/12
  • Tom Fuerst
  • 0 min. 0 sec.
Video 6 of 9 Tom Fuerst Shares Thoughts on Outsourcing
  • Tom Fuerst - Panel - Intersection of Opportunity: Business and the Life Science
  • 4/19/12
  • Tom Fuerst
  • 0 min. 0 sec.
Video 7 of 9 Tom Fuerst Discusses Raising Capital And Having Intellectual Property In Order
  • Tom Fuerst - Panel - Intersection of Opportunity: Business and the Life Science
  • 4/19/12
  • Tom Fuerst
  • 0 min. 0 sec.
Video 8 of 9 Tom Fuerst Discusses Intellectual Property Protection
  • Tom Fuerst - Panel - Intersection of Opportunity: Business and the Life Science
  • 4/19/12
  • Tom Fuerst
  • 0 min. 0 sec.
Video 9 of 9 Tom Fuerst Shares Advice on Building A Life Science Startup
  • Tom Fuerst - Panel - Intersection of Opportunity: Business and the Life Science
  • 4/19/12
  • Tom Fuerst
  • 0 min. 0 sec.